Exact Mass: 890.2058048000001

Exact Mass Matches: 890.2058048000001

Found 9 metabolites which its exact mass value is equals to given mass value 890.2058048000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

2,3-diene-Valproic acid-CoA

1-({2-[(3-{[4-({[({[(2S,3R,4S,5S)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulfanyl)-1-oxo-2-[(1E)-prop-1-en-1-yl]pentan-3-yl

C29H47N7O17P3S (890.1961902)

2,3-diene-Valproic acid-CoA is a metabolite of valproic acid. Valproic acid (VPA) is a chemical compound and an acid that has found clinical use as an anticonvulsant and mood-stabilizing drug, primarily in the treatment of epilepsy, bipolar disorder, and, less commonly, major depression. It is also used to treat migraine headaches and schizophrenia. VPA is a liquid at room temperature, but it can be reacted with a base such as sodium hydroxide to form the salt sodium valproate, which is a solid. (Wikipedia)

7,4beta-

8)-epiafzelechin-(4beta-

C47H38O18 (890.2058048000001)

cyanidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(cis-p-coumaroyl)-beta-D-glucopyranoside]-5-O-[beta-D-glucopyranoside]

C41H46O22 (890.2480616)

Epiafzelechin-(2beta->7,4beta->8)-epiafzelechin-(4beta->8)-dryopteric acid

C47H38O18 (890.2058048000001)

Faldaprevir sodium

C40H48BrN6NaO9S (890.2284378)

C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[6,9,17,19,21-pentahydroxy-5,13-bis(4-hydroxyphenyl)-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2,8,10,15,17,19-hexaen-7-yl]-3,4-dihydro-2h-1-benzopyran-4-yl]acetic acid

[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[6,9,17,19,21-pentahydroxy-5,13-bis(4-hydroxyphenyl)-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2,8,10,15,17,19-hexaen-7-yl]-3,4-dihydro-2h-1-benzopyran-4-yl]acetic acid

C47H38O18 (890.2058048000001)

6-[(4a-{[9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-4a-yl]sulfanyl}-9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-8-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[(4a-{[9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-4a-yl]sulfanyl}-9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-8-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C40H42O21S (890.1939202000001)

[(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[(1r,5r,6r,7s,13s,21r)-6,9,17,19,21-pentahydroxy-5,13-bis(4-hydroxyphenyl)-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2,8,10,15,17,19-hexaen-7-yl]-3,4-dihydro-2h-1-benzopyran-4-yl]acetic acid

[(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[(1r,5r,6r,7s,13s,21r)-6,9,17,19,21-pentahydroxy-5,13-bis(4-hydroxyphenyl)-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2,8,10,15,17,19-hexaen-7-yl]-3,4-dihydro-2h-1-benzopyran-4-yl]acetic acid

C47H38O18 (890.2058048000001)

(2r,3r,4r,5s,6r)-6-{[(1s,3s,4as,10ar)-4a-{[(1s,3s,4as,10ar)-9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-4a-yl]sulfanyl}-9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-8-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2r,3r,4r,5s,6r)-6-{[(1s,3s,4as,10ar)-4a-{[(1s,3s,4as,10ar)-9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-4a-yl]sulfanyl}-9,10a-dihydroxy-3-(2-methoxy-2-oxoethyl)-1-methyl-5,10-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-8-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C40H42O21S (890.1939202000001)